Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Isopropyl alcohol + povidone-iodine + triamcinolone** is a combination procedural kit used to support corticosteroid injection, containing antiseptic skin-preparation components and a therapeutic corticosteroid component. The pharmacologically active drug is **triamcinolone acetonide** injectable suspension, a synthetic glucocorticoid receptor agonist that suppresses inflammatory and immune signaling; **isopropyl alcohol** and **povidone-iodine** serve as topical antiseptics for pre-injection skin cleansing rather than as systemic therapeutic agents. In the provided context, the kit corresponds to P-CARE-branded packs built around **Kenalog-40** or **Kenalog-80** injection presentations and is associated with intramuscular, intra-articular, and soft-tissue corticosteroid use across allergic, dermatologic, rheumatologic, hematologic, gastrointestinal, respiratory, renal, neurologic, ophthalmic, endocrine, and neoplastic indications when corticosteroid injection is clinically appropriate.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on isopropyl alcohol + povidone-iodine + triamcinolone.